scieee Open visual document viewer

PRISMAP Deliverable D10.4 - Report on ion source efficiency for a 11C PET ISOL beam

Gambino, Nadia; Orsolic, Marjan; Penescu, Liviu; Schmitzer, Claus

Abstract

The goal of this research activity task was to identify potential solutions to establish radioactive ion beams in the form of C-11 in a clinical ion beam therapy accelerator complex. Previous studies [1],[2] provided prototypes of C-11 production targets and concepts for overall integration. A crucial component is the ion source to ionize that scarcely produced radioactive gas.Three ion source options have been tested with CO2 gas to assess their performance and gas efficiency in an attempt to mimic similar conditions as provided by the production target prototype. A 14.5 GHz Supernanogan ECR source at MedAustron, a FEBIAD VADIS MK7 at CERN and a 2.4 GHz COMIC ECR source at The University of Manchester were studied under lab conditions by MedAustron and CERN staff. The Supernanogan ion source is a commercial compact Electron Cyclotron Resonance (ECR) ion source, whereas the FEBIAD and COMIC sources originate from the ISOL domain, in particular relying on the extensive experience accumulated over the years at the most representative ISOL facility, ISOLDE.Measurements have confirmed that the Supernanogan ion source demonstrates relatively low gas efficiency (observed maximum 0.6%). While it did not meet the particle output necessary for therapeutic applications, it still presents a viable option due to its operational simplicity. One key advantage is its compatibility with direct injection into an existing linear accelerator, eliminating the need for a mass separator or charge breeder—components that typically lead to additional particle losses and complexity.Despite falling short of the requirements for full clinical use, the current setup is still suitable for generating diagnostic carbon beams at low intensity (estimated 4x107 particles). These can be valuable for applications such as physiological and range verification in treatment planning. However, while academically interesting, its practical use in a clinical setting is doubtful. The primary concern is its negative impact on workflow efficiency, particularly the increased in-room time required for patients during irradiation procedures.To improve the Supernanogan’s performance, a possible upgrade involves integrating a cryogenic trap, similar to the one used in the Krion electron string ion source [9]. This would allow for a more concentrated release of radioactive carbon monoxide through pulsed sublimation into the plasma chamber, potentially increasing ion production efficiency. However, further studies are needed to assess how significantly this setup could enhance the yield of C4+ ions. In addition, issues like beam reproducibility and long-term stability throughout treatment sessions must be carefully evaluated.While observed COMIC efficiencies and intensities were too low to prove useful in the envisaged setup (observed maximum 0.35%), the FEBIAD ion source demonstrated more favourable gas efficiencies. The FEBIAD source, in particular, performed well at low gas pressures (observed maximum 5.4%), making it a strong candidate for use with the proposed boron nitride (BN) target. However, a limitation of this source is its inability to efficiently produce high charge states. As a result, its implementation would necessitate both a mass separator and a charge breeder. While the required mass resolution is relatively modest and thus technically achievable, the charge breeder itself would need to be highly capable—able to deliver around 1x1011 particles per pulse. This would likely require enhancements to existing EBIS (Electron Beam Ion Source) designs to meet those output levels.An alternative and potentially more robust solution could be the use of a cryogenic trap in combination with a high-performance electron string ion source, such as the TESIS system. TESIS has shown promising results for producing carbon beams at the required charge states for therapeutic purposes. Since similar sources have already been successfully integrated with cryotraps, this configuration could meet both the intensity and quality demands of carbon ion therapy.In conclusion, while the Supernanogan ion source in its current form is not suitable for therapeutic applications due to low particle yield, its simplicity and potential for upgrades may justify further research. Meanwhile, sources like FEBIAD and advanced systems like TESIS offer more immediate pathways toward achieving the necessary beam quality and quantity, particularly when paired with appropriate separation and breeding technologies. Ongoing development and refinement of these systems are critical to ensuring practical, high-efficiency solutions for clinical C-11 ion beam therapy.

Full text

Deli e able D10.4 Repo on ion sou ce e iciency o a 11C PET ISOL beam This p ojec has ecei ed unding om he Eu opean Union’s Ho izon 2020 esea ch and inno a ion p og amme unde g an ag eemen No 101008571 (PRISMAP). This documen e lec s only he iew o he au ho (s). The Agency is no esponsible o any use ha may be made o he in o ma ion i con ains. Deli e able D10.4 ii P ojec Ac onym PRISMAP P ojec Ti le The Eu opean medical iso ope p og amme: P oduc ion o high pu i y iso opes by mass sepa a ion G an Ag eemen No. 101008571 Topic INFRAIA-02-2020: In eg a ing Ac i i ies o S a ing Communi ies P ojec s a da e 01 May 2021 Na u e Repo Dissemina ion le el Public Due da e M52 Da e o deli e y M52 Lead pa ne MedAus on Con ibu ing pa ne CERN Au ho s N. Gambino, M. O solic, L. Penescu, C. Schmi ze (MedAus on) Re iewe s T.E. Cocolios (KULeu en), S. Ro he (CERN), M. Manzola o (INFN) Poin o Con ac C. SCHMITZER Ins i u ion MedAus on E-mail Claus.schmi ze @medaus on.a Phone +4366480878839 © PRISMAP 2021. This wo k is licensed unde a C ea i e Commons A ibu ion-NonComme cial-NoDe i a i es 4.0 In e na ional License. Deli e able D10.4 iii Re ision His o y Ve sion Da e Au ho Commen 0.1 09.07.2025 M. O solic, L. Penescu, C. Schmi ze Fi s d a 0.2 01.08.2025 M. O solic, L. Penescu, C. Schmi ze Final d a o e iew 0.3 14.08.2025 S. Ro he, M. Manzola o, T.E. Cocolios In e nal e iew 0.4 21.08.2025 M. O solic, L. Penescu, C. Schmi ze Re ised e sion 0.9 25.08.2025 V. Gob y, K. Leu gen Re iew and o ma ing 0.91 28.08.2025 M. Manzola o, K. Leu gen Ve sion o inal e iew and app o al by he PRISMAP gene al assembly (GA) 1.0 29.08.2025 K. Leu gen Final e sion, app o ed by he GA Deli e able D10.4 i Con en s Abb e ia ions, Pa icipan sho names Abb e ia ions Pa icipan sho names Lis o Figu es ii Lis o Tables ii Summa y 1 1. Con ex 2 2. Mo i a ion 2 2.1 Limi a ions in cu en clinical se up 2 2.2 Expec ed a ge ou pu 3 2.3 Po en ial o e all in eg a ion 3 3. Supe nanogan es esul s 4 3.1 Conclusion and possible use o Supe nanogan 6 4. VADIS MK7 es esul s 6 4.1 Sou ce es ing wi h noble gas mix u e 7 4.2 Sou ce uning o ope a ion wi h [C-12]CO2 8 4.3 E iciency measu emen wi h [C-13]CO2 11 5. COMIC es esul s 11 6. Conclusion and ou look 14 Re e ences 15 Deli e able D10.4 Abb e ia ions, Pa icipan sho names Abb e ia ions COMIC Compac Mic owa e and Coaxial EBIS Elec on Beam Ion Sou ce ECR Elec on Cyclo on Resonance FEBIAD Fo ced Elec on Beam Induced A c Discha ge ISOLDE Iso ope Sepa a o Online De ice LPSC Labo a oi e de Physique Suba omique e de Cosmologie PET-CT Posi on Emission Tomog aphy – Compu ed Tomog aphy RF adio equency SPS Spa k Plasma Sin e ing TESIS Tubula Elec on S ing Ion Sou ce VADIS Ve sa ile A c Discha ge Ion Sou ce Pa icipan sho names CERN Eu opean o ganisa ion o nuclea esea ch NPL Na ional Physical Labo a o y PSI Paul Sche e Ins i u CEA Commissa ia à l’éne gie a omique e aux éne gies al e na i es IST-ID Associação do Ins i u o Supe io Técnico pa a a IST-ID In es igação e Desen ol imen o DTU Danma ks Tekniske Uni e si e CHUV Cen e hospi alie uni e si ai e audois GANIL G and Accélé a eu Na ional d’Ions Lou ds SCK CEN S udiecen um oo Ke nene gie / Cen e d'é ude de l'éne gie nucléai e ARRONAX G oupemen d’in é ê public ARRONAX ESS Eu opean spalla ion sou ce ERIC TUM Klinikum ech s de Isa de echnischen Uni e si ä München KULeu en Ka holieke Uni e si ei Leu en MedAus on En wicklungs- und Be iebsgesellscha MedAus on GmbH SCIPROM SCIPROM Sà l MUI Medizinische Uni e si ä Innsb uck ILL Ins i u Max on Laue - Paul Lange in Deli e able D10.4 i JRC JRC -Join Resea ch Cen e- Eu opean Commission NCBJ Na odowe Cen um Badań Jąd owych GSI GSI Helmhol zzen um  Schwe ionen o schung GmbH LU La ijas Uni e si ā e INFN Is i u o Nazionale di Fisica Nuclea e UiO Uni e si e e i Oslo Deli e able D10.4 ii Lis o Figu es Figu e 1: CO2 o C4+ ionisa ion e iciency wi h espec o CO2/He gas injec ion 5 Figu e 2: CO2 o C4+ ionisa ion e iciency wi h espec o CO2/A gas injec ion 5 Figu e 3: E ec o u bo pump powe on he CO₂ o C4⁺ ionisa ion e iciency, o he bes a io o He o CO2 iden i ied in Figu e 1. The o he sou ce se ings a e he ones gi en in Table 2. 6 Figu e 4: Ionisa ion e iciency o noble gas mix u e (helium, neon, a gon, k yp on, xenon). Ope a ing pa ame e s: ca hode empe a u e: 2020 °C, ion sou ce magne : 27.5 mT, anode ol age: 250 V 7 Figu e 5: To al ion cu en as a unc ion o anode ol age a di e en gas injec ion alues wi h noble gas mix u e. No e: Al hough he eed injec ion comp ises i e noble gases in equal p opo ions (20 % each), his a io shi s inside he ion sou ce because he low leak a e allows ligh e a oms o en e mo e easily han hea ie ones. The ac ual composi ion is helium 46 %, neon 21 %, a gon 15 %, k yp on 10 %, and xenon 8 %. Ope a ional pa ame e s: ca hode empe a u e: 2020 °C, ion sou ce magne : 30 mT 8 Figu e 6: CO2 o CO+ ionisa ion e iciency wi h CO2 gas as a unc ion o he ca hode empe a u e. Ope a ing pa ame e s: CO2 gas injec ion o 5.45 x 1014 pps, ion sou ce magne : 30 mT, anode ol age: 250 V 9 Figu e 7: CO+ cu en as a unc ion o he ion sou ce magne ic ield s eng h. Ope a ing pa ame e s: CO2 gas injec ion o 2.79 x 1014 pps, ca hode empe a u e: 2107 °C, anode ol age: 200 V 9 Figu e 8: Ionisa ion e iciency a io o CO+/CO2+, C+/CO2+ and C+/CO+ as a unc ion CO2 gas injec ion. Ope a ional pa ame e s: ca hode empe a u e: 2020 °C, ion sou ce magne : 30 mT, anode ol age: 250 V 10 Figu e 9: Ionisa ion e iciency a io o CO+/CO2+, C+/CO2+ and C+/CO+ o he COMIC ion sou ce as a unc ion o o wa d powe . CO2 gas injec ion o 2.24 x 1016 pps 12 Figu e 10: CO+, CO2+ and C+ cu en as a unc ion o ime o a 200 ms mic owa e pulse. CO2 gas injec ion o 2.24 x 1016 pps 12 Figu e 11: CO+ cu en as a unc ion bu e gas injec ion o (a) a gon and (b) helium. CO2 gas injec ion o 3.32 x 1016 pps, o wa d powe 20 W 13 Lis o Tables Table 1: Expec ed gas ou pu om he BN a ge when ope a ed a 1500 °C wi h a con olled oxygen leak, and beam on a ge as a ailable om he 18 MeV Cyclone KIUBE 3 Table 2: Op imised ion sou ce se ing o C4+ ope a ion 4 Table 3: Ionisa ion e iciencies o CO+, CO2+ and C+ o CO2 gas injec ion a di e en leak p essu e alues, unco ec ed o backg ound ca bon coming om he ion sou ce ma e ials. Ope a ing pa ame e s: ca hode empe a u e: 2020 °C, ion sou ce magne : 30 mT, anode ol age: 250 V 10 Table 4: The measu ed alues o CO+ ionisa ion e iciencies. No backg ound was obse ed a mass 29. A anspo e iciency o 80% is conside ed om he ion sou ce o he Fa aday cup loca ed a e he sepa a o magne . 11 Summa y The goal o his esea ch ac i i y ask was o iden i y po en ial solu ions o es ablish adioac i e ion beams in he o m o C-11 in a clinical ion beam he apy accele a o complex. P e ious s udies [1],[2] p o ided p o o ypes o C-11 p oduc ion a ge s and concep s o o e all in eg a ion. A c ucial componen is he ion sou ce o ionize ha sca cely p oduced adioac i e gas. Th ee ion sou ce op ions ha e been es ed wi h CO2 gas o assess hei pe o mance and gas e iciency in an a emp o mimic simila condi ions as p o ided by he p oduc ion a ge p o o ype. A 14.5 GHz Supe nanogan ECR sou ce a MedAus on, a FEBIAD VADIS MK7 a CERN and a 2.4 GHz COMIC ECR sou ce a The Uni e si y o Manches e we e s udied unde lab condi ions by MedAus on and CERN s a . The Supe nanogan ion sou ce is a comme cial compac Elec on Cyclo on Resonance (ECR) ion sou ce, whe eas he FEBIAD and COMIC sou ces o igina e om he ISOL domain, in pa icula elying on he ex ensi e expe ience accumula ed o e he yea s a he mos ep esen a i e ISOL acili y, ISOLDE. Measu emen s ha e con i med ha he Supe nanogan ion sou ce demons a es ela i ely low gas e iciency (obse ed maximum 0.6%). While i did no mee he pa icle ou pu necessa y o he apeu ic applica ions, i s ill p esen s a iable op ion due o i s ope a ional simplici y. One key ad an age is i s compa ibili y wi h di ec injec ion in o an exis ing linea accele a o , elimina ing he need o a mass sepa a o o cha ge b eede —componen s ha ypically lead o addi ional pa icle losses and complexi y. Despi e alling sho o he equi emen s o ull clinical use, he cu en se up is s ill sui able o gene a ing diagnos ic ca bon beams a low in ensi y (es ima ed 4x107 pa icles). These can be aluable o applica ions such as physiological and ange e i ica ion in ea men planning. Howe e , while academically in e es ing, i s p ac ical use in a clinical se ing is doub ul. The p ima y conce n is i s nega i e impac on wo k low e iciency, pa icula ly he inc eased in- oom ime equi ed o pa ien s du ing i adia ion p ocedu es. To imp o e he Supe nanogan’s pe o mance, a possible upg ade in ol es in eg a ing a c yogenic ap, simila o he one used in he K ion elec on s ing ion sou ce [9]. This would allow o a mo e concen a ed elease o adioac i e ca bon monoxide h ough pulsed sublima ion in o he plasma chambe , po en ially inc easing ion p oduc ion e iciency. Howe e , u he s udies a e needed o assess how signi ican ly his se up could enhance he yield o C4+ ions. In addi ion, issues like beam ep oducibili y and long- e m s abili y h oughou ea men sessions mus be ca e ully e alua ed. While obse ed COMIC e iciencies and in ensi ies we e oo low o p o e use ul in he en isaged se up (obse ed maximum 0.35%), he FEBIAD ion sou ce demons a ed mo e a ou able gas e iciencies. The FEBIAD sou ce, in pa icula , pe o med well a low gas p essu es (obse ed maximum 5.4%), making i a s ong candida e o use wi h he p oposed bo on ni ide (BN) a ge . Howe e , a limi a ion o his sou ce is i s inabili y o e icien ly p oduce high cha ge s a es. As a esul , i s implemen a ion would necessi a e bo h a mass sepa a o and a cha ge b eede . While he equi ed mass esolu ion is ela i ely modes and hus echnically achie able, he cha ge b eede i sel would need o be highly capable—able o deli e a ound 1x1011 pa icles pe pulse. This would likely equi e enhancemen s o exis ing EBIS (Elec on Beam Ion Sou ce) designs o mee hose ou pu le els. An al e na i e and po en ially mo e obus solu ion could be he use o a c yogenic ap in combina ion wi h a high-pe o mance elec on s ing ion sou ce, such as he TESIS sys em. TESIS has shown p omising esul s o p oducing ca bon beams a he equi ed cha ge s a es o he apeu ic pu poses. Since simila sou ces ha e al eady been success ully in eg a ed wi h c yo aps, his con igu a ion could mee bo h he in ensi y and quali y demands o ca bon ion he apy. In conclusion, while he Supe nanogan ion sou ce in i s cu en o m is no sui able o he apeu ic applica ions due o low pa icle yield, i s simplici y and po en ial o upg ades may jus i y u he esea ch. Meanwhile, sou ces like FEBIAD and ad anced sys ems like TESIS o e mo e immedia e pa hways owa d achie ing he necessa y beam quali y and quan i y, pa icula ly when pai ed wi h app op ia e sepa a ion and b eeding echnologies. Ongoing de elopmen and e inemen o hese sys ems a e c i ical o ensu ing p ac ical, high-e iciency solu ions o clinical C-11 ion beam he apy. Deli e able D10.4 2 1. Con ex One p ominen quali y assu ance limi a ion o pa icle-based adia ion he apy is o e i y he 3-dimensional loca ion o he B agg peak and hus he deposi ed dose wi hin he pa ien . While he ion beam posi ion and incoming ene gy can be well de e mined, he pa ien ’s physiology will change o e he cou se o he ea men which usually las s se e al weeks. As he ion beam dose deposi ion is e ec i ely an implan a ion p ocess, he use o adioac i e iso opes as p ima y ion beam could enable in- i o moni o ing o he dose loca ion. Posi on emi e s like C-11 would hus enable he use o s anda d PET-CTs o di ec co ela ion be ween he PET signal and he deployed dose dis ibu ion. While his is also possible using s able C-12, using an ac i e posi on emi e inc eases he signal by an o de o magni ude and esul s in a be e signal o noise a io, hus imp o ing imaging quali y. As his me hod can be employed du ing no mal ea men , no ex a machine ime o o he dedica ed imaging CT sessions a e equi ed. E e y ea men session can be used o ga he new quali y assu ance da a and igge a necessa y upda e o he ea men plan o ake physiology changes in o accoun . Addi ional online moni o ing will also help o educe ange unce ain ies and help gua an ee he equi ed sa e y ma gins. While he i s applica ion would be pos - ea men imaging o p o ide mo e da a on he pa ien ’s ea men esponse, in he u u e, in- i o online dose e i ica ion will imp o e umou a ge ing and suppo 4- dimensional ea men planning. In o de o p o ide a C-11 beam, high yield p oduc ion a ge s ha e o be used [1] and e y e icien adioac i e ion beam lines a e equi ed. Cu en accele a o anspo e iciency demands a ound 1x1011 C4+ o C6+ pa icles pe second a he sou ce le el o p o ide su icien in ensi y o p o icien ea men . The sca ce amoun o [C-11]CO gas esul s in igh equi emen s o ion sou ce gas e iciency. An ex ensi e analysis o he possible echnical solu ions o he implemen a ion o C-11 adioiso opes in an accele a o -based pa icle he apy cen e was done unde he MEDICIS-PROMED Ho izon 2020 p ojec [2]. In his epo we will p esen he wo k conduc ed a MedAus on, CERN and The Uni e si y o Manches e on ca bon ion sou ce cha ac e isa ion in iew o gas e iciency o po en ial C-11 adioac i e ion beam lines. 2. Mo i a ion 2.1 Limi a ions in cu en clinical se up C-12 beams a e gene a ed in pa icle he apy cen es using high-pe o mance ECR ion sou ces. These ion sou ces gene ally deli e cu en s o o e 100 mic oampe es (µA) in con inuous mode, o , mo e ecen ly, also in a long-pulse (>100 ms) mode. In bo h cases, howe e , almos all o he gene a ed beam is disca ded, as he ion beam can only be injec ed in o he synch o on wi hin a ime window o a ew ens o ms. As s able C-12 is a ailable in su icien quan i ies, hese losses do no pose a p oblem. Radioac i e pa icle beams p esen a di e en si ua ion. Medical synch o ons a e usually illed once e e y 1-10 seconds. The beam is subsequen ly accele a ed and hen ex ac ed h oughou an ex ac ion spill which las s up o 8 seconds be o e he nex illing cycle s a s. Radioiso ope p oduc ion is a complica ed and cos ly p ocess which he e o e calls o e icien use o he sho -li ed adioiso opes. The ime be ween spills should he e o e be used o accumula e he pa icles o ensu e he in ensi y equi ed o i adia ion. Each s ep mus achie e high e iciency o ensu e ha he la ges possible p opo ion o he p oduced pa icles is accele a ed. Howe e , he ion sou ces cu en ly used in pa icle he apy cen es a e no designed o high gas e iciencies and hus no in insically op imised o he low gas low a es ypically expec ed om a ge ma e ials. Fu he mo e, hese ion sou ces ha e no s o age capaci y. An EBIS- ype cha ge b eeding sys em was he e o e p oposed o mee he equi emen s. Deli e able D10.4 9 Figu e 6: CO2 o CO+ ionisa ion e iciency wi h CO2 gas as a unc ion o he ca hode empe a u e. Ope a ing pa ame e s: CO2 gas injec ion o 5.45 x 1014 pps, ion sou ce magne : 30 mT, anode ol age: 250 V Inc easing he ca hode empe a u e om app oxima ely 1,900 °C o 2,100 °C causes he mionic elec on emission o inc ease, as illus a ed in Figu e 6, in ag eemen wi h he Richa dson–Dushman equa ion 𝑗 ∝ 𝑇2𝑒𝛼/𝑇. As he anode d ain cu en (which is a measu e o he he mionic emission cu en ) inc eases, he CO2 o CO+ e iciency also imp o es. The ise o he elec on densi y, howe e , deepens he elec os a ic po en ial well in he anode chambe , desc ibed in E o ! Re e ence sou ce no ound. as he inac i e olume. This is he space in which ions emain apped in he po en ial unnel and can no longe be ex ac ed. As a esul , he p opo ion o he ac i e olume om which CO⁺ ions can ac ually escape dec eases, and he CO⁺ e iciency eaches a pla eau despi e u he inc ease o he elec on emission. Figu e 7: CO+ cu en as a unc ion o he ion sou ce magne ic ield s eng h. Ope a ing pa ame e s: CO2 gas injec ion o 2.79 x 1014 pps, ca hode empe a u e: 2107 °C, anode ol age: 200 V The VADIS ope a es wi hin a weak axial magne ic ield gene a ed by a solenoid. As he cu en in he ion sou ce magne inc eases, a shi in CO₂ o CO⁺ e iciency can be obse ed (Figu e 7), which can be explained by he p esence o wo compe ing mechanisms [5]. On he one hand, he magne ic ield o ces he elec ons Deli e able D10.4 10 in o spi al o bi s, hus ex ending hei esidence ime in he anode ca i y, which signi ican ly imp o es he p obabili y o ionisa ion. A he same ime, he inc eased elec on accumula ion in he anode cen e leads o he o ma ion and deepening o he p e iously men ioned inac i e olume. The p oduced CO⁺ ions emain apped and can no longe be ex ac ed. The bes ionisa ion e iciency was measu ed a highe magne ic ield s eng hs. A highe gas injec ion a es, he ex ac ed cu en sa u a es due o space cha ge limi a ions acco ding o he Child-Langmui equa ion. This e ec educes he o e all ionisa ion e iciency, as shown in Table 3. Table 3: Ionisa ion e iciencies o CO+, CO2+ and C+ o CO2 gas injec ion a di e en leak p essu e alues, unco ec ed o backg ound ca bon coming om he ion sou ce ma e ials. Ope a ing pa ame e s: ca hode empe a u e: 2020 °C, ion sou ce magne : 30 mT, anode ol age: 250 V Leak p essu e [mba ] Injec ed C02 gas (pps) CO+ [%] CO2+ [%] C+ [%] 254 2.76 x 1014 6.5 1.56 0.68 456 4.95 x 1014 4.7 1.74 0.50 952 1.03 x 1015 3.4 1.66 0.34 1454 1.58 x 1015 2.5 1.30 0.25 The da a om Table 3 is p esen ed in Figu e 8 as a ios be ween he di e en ca bon compounds, o illus a e how he chemical equilib ium e ol es inside he ion sou ce depending on he injec ed gas amoun . I is obse ed ha he imp o emen o he CO+ ionisa ion e iciency a lowe alues o he injec ed gas is no only due o an o e all imp o emen o he ionisa ion e iciencies, bu also o an imp o emen o he a io CO/CO2. The a io C/CO is una ec ed by he amoun o injec ed gas. Figu e 8: Ionisa ion e iciency a io o CO+/CO2+, C+/CO2+ and C+/CO+ as a unc ion CO2 gas injec ion. Ope a ional pa ame e s: ca hode empe a u e: 2020 °C, ion sou ce magne : 30 mT, anode ol age: 250 V These measu emen s led o he ollowing conclusions:  The ca bon compound wi h he bes ionisa ion e iciency is CO+ Deli e able D10.4 11  The ion sou ce has be e ionisa ion e iciencies when less gas is injec ed  The bes se ings o use o he ion sou ce a e:  Line empe a u e be ween 2050°C and 2100°C  Anode ol age a 250 V  Solenoid magne a 6A (which gene a es a magne ic ield es ima ed a 30 mT)Table 4 4.3 E iciency measu emen wi h [C-13]CO2 The goal o he es wi h [C-13]CO2 was o ob ain a eliable measu emen o he ionisa ion e iciency o he ca bon molecules, because he VADIS has inhe en ly a backg ound o C-12 ions when ope a ed a high empe a u es. A e pe o ming anode ol age, magne and line hea ing scans, he se ings iden i ied in sec ion 4.2 we e con i med as op imal and yielded he ollowing esul s o C-13 (see Table 4), which a e expec ed o also ep esen he C-11 e iciencies. Table 4: The measu ed alues o CO+ ionisa ion e iciencies. No backg ound was obse ed a mass 29. A anspo e iciency o 80% is conside ed om he ion sou ce o he Fa aday cup loca ed a e he sepa a o magne . Measu emen s a mass 29 a e no a ec ed by any backg ound as he e was no con amina ion obse ed a his mass du ing he es s wi h noble gases and wi h C-12. An impo an con amina ion (on he o de o µA) was s ill obse ed a mass 28, o empe a u es abo e 1900 °C. This con amina ion was inc easing du ing he ope a ion wi h [C-12]CO2. Du ing he es s wi h noble gases, he con amina ion was ound o be negligible (on he o de o a ew nanoampe es). 5. COMIC es esul s The 2.45 GHz COMIC (Compac Mic owa e and Coaxial) ion sou ce was designed as an ul a-compac ECR sou ce a he LPSC in G enoble in close collabo a ion wi h CERN ISOLDE. The ollowing sec ion p o ides an o e iew o he es s conduc ed a The Uni e si y o Manches e wi h ega d o C-11 compa ibili y. Leak p essu e [mba ] Injec ed 13C02 gas (pps) 13CO+ [A] 13CO+ [%] 250 2.71 x 1014 1.87 5.4 500 5.43 x 1014 2.64 3.8 Deli e able D10.4 12 Figu e 9: Ionisa ion e iciency a io o CO+/CO2+, C+/CO2+ and C+/CO+ o he COMIC ion sou ce as a unc ion o o wa d powe . CO2 gas injec ion o 2.24 x 1016 pps Figu e 9 shows ha he CO/CO₂ a io inc eases wi h highe mic owa e powe . This is possibly due o he inc ease in elec on densi y, which is impo an o he neu al dissocia ion o CO₂. Ini ially, elec ons spli CO₂ p edominan ly in o CO and O (neu al dissocia ion ene gy 5.5 eV), wi h CO subsequen ly being mo e easily ionised o CO⁺ (ionisa ion ene gy 13.8 eV) [6]. In addi ion, he p opo ion o ho elec ons also inc eases wi h highe mic owa e powe , which a ou s he di ec ionisa ion o CO₂ o CO⁺ (dissocia i e ionisa ion ene gy 19.5 eV) [7]. The e o e, he CO/CO₂ a io inc eases un il equilib ium is eached a highe powe s, as almos all a ailable CO₂ molecules ha e al eady been con e ed. The o ma ion o C⁺, on he o he hand, emains e y low, because e en highe elec on ene gies a e equi ed. As a esul , bo h C/CO₂ and C/CO each only low alues. Figu e 10: CO+, CO2+ and C+ cu en as a unc ion o ime o a 200 ms mic owa e pulse. CO2 gas injec ion o 2.24 x 1016 pps (a) Deli e able D10.4 13 Figu e 10 shows he CO₂⁺, CO+ and C+ ion cu en o a 200 ms mic owa e pulse. Fo he CO2+ cu en , a apid inc ease and o e shoo can be seen, ollowed by a signi ican d op o a s eady pla eau. A e he ini ial deple ion o CO2 and he di ec p oduc ion o CO2+ s abilises, he s epwise ionisa ion o o he species and dissocia i e p oduc s akes o e [8]. This esul s in a sho - e m cu en peak o CO₂⁺ ions. Sho ly a e , he CO₂⁺ cu en d ops again which may ha e se e al causes ha occu simul aneously. Fi s , some o he CO₂ is no only ionised by elec on collisions, bu also dissocia ed (dissocia ion ene gy 5.5 eV), p oducing CO and a omic oxygen. This educes he CO₂ concen a ion in he plasma, lea ing ewe molecules a ailable o di ec ionisa ion o CO₂⁺. Second, CO₂⁺ ions ha ha e al eady been p oduced a e u he con e ed in o CO⁺ o o he ions by cha ge ans e and collision p ocesses, which u he educes he CO₂⁺ cu en . CO+ and C+ cu en s show a apid inc ease up o a pla eau, in ag eemen wi h expec a ions. Figu e 11: CO+ cu en as a unc ion bu e gas injec ion o (a) a gon and (b) helium. CO2 gas injec ion o 3.32 x 1016 pps, o wa d powe 20 W Di e en bu e gases ha e been injec ed in o de o a emp an e iciency boos o CO and CO2 ion p oduc ion. Resul s o a gon and helium es s a e illus a ed in Figu e 11. The CO⁺ cu en dec eases in bo h in es iga ed cases wi h inc easing injec ion o bu e gases. When a gon is used, he plasma is only s able (a) (b) Deli e able D10.4 14 wi hin a e y na ow ange, whe eas helium allows o a signi ican ly b oade s able ope a ing window. Compa ed o ope a ing he sou ce exclusi ely wi h CO₂, he addi ion o bu e gases has an o e all supp essing e ec on CO⁺ p oduc ion, as he achie able ion cu en in bo h cases emains below he alues o pu e CO₂ ope a ion. The highes measu ed CO⁺ cu en was app oxima ely 6 µA wi h a CO₂ gas injec ion o 1.34 × 10¹⁷ pps and a o wa d powe o 50 W. Despi e he o e all lowe CO⁺ cu en yield, howe e , he bu e gases enable a s able plasma ope a ion a lowe CO₂ gas injec ion a es while s ill main aining good CO⁺ cu en s. The bes measu ed CO₂ o CO⁺ e iciency was 0.35% wi h an a gon injec ion o 2.24 × 10¹⁶ pps, a CO₂ injec ion o 4.93 × 10¹⁵ pps, and a o wa d powe o 20 W. 6. Conclusion and ou look Conduc ed measu emen s ha e con i med a a he low gas e iciency o he Supe nanogan ion sou ce. Al hough i was no possible o achie e he ea men equi emen s in e ms o numbe o pa icles, i emains a iable se up due o i s ad an age o simplici y. The ECR ion sou ce can di ec ly injec in o an exis ing linea accele a o and does no equi e any mass sepa a o o cha ge b eede which by hemsel es ye educe he ansmi ed pa icle coun . Cu en esul s will only su ice o diagnos ic ca bon beams which can be used o physiology and ange e i ica ions. Al hough in e es ing om an academic poin o iew i is e y unlikely ha such a se up would be applied o clinical use sincei will inc ease o e all in- oom ime o he pa ien in he i adia ion oom. In o de o boos he o e all pe o mance, he Supe nanogan could be equipped wi h a c yogenic ap as implemen ed in he K ion [9] elec on s ing ion sou ce. This would enable a highe concen a ion o [C-11]CO ollowed by a pulsed sublima ion elease [9] in o he plasma chambe . I emains o be s udied how much he C4+ p oduc ion can be boos ed wi h such a se up. Addi ional poin s o add ess would be ep oducibili y and s abili y h oughou he du a ion o a ea men . The obse ed gas e iciencies o he o he es ed and op imised sou ces, especially he FEBIAD, show p omising pe o mances. The FEBIAD also shows a good pe o mance a low gas p essu es which makes i a sui able candida e o use wi h he en isaged BN a ge . Un o una ely, only low cha ge s a es can be gene a ed e icien ly which esul s in he need o a dedica ed cha ge b eede and ano he mass sepa a o . The e iciency o his p ocess was e alua ed in [2], whe e i was ound ha o a combina ion o a ap and EBIS cha ge b eede , a maximum e iciency o 8% o he con e sion o CO1+ o C6+ can be achie ed. Ye his e iciency was dec easing owa ds 1% wi h inc easing numbe o C6+ ions pe pulse, due o space cha ge limi a ions and o he high collec ion ime on he ap compa ed o he s anda d ope a ion (on he o de o 100 ms, ins ead o ew µs). I we assume an a e age e iciency o 5% o his cha ge b eeding s ep, oge he wi h he VADIS ionisa ion e iciency o abou 5%, we ob ain a o al e iciency o 0.25%, which is below he measu ed ionisa ion e iciency o Supe nanogan, which does no equi e hese addi ional s eps. Ano he po en ial solu ion could be a combina ion o a c yogenic ap wi h a high-pe o mance elec on s ing ion sou ce called TESIS [11] which p omises sui able beam cu en s o he equi ed ca bon cha ge s a es o ion beam he apy. As simila ion sou ces ha e al eady been equipped and es ed wi h such c yo aps, such a se up p omises he equi ed beam in ensi ies o ea men . Deli e able D10.4 15 Re e ences [1] S. S egemann e al., “A po ous hexagonal bo on ni ide powde compac o he p oduc ion and elease o adioac i e 11C,” Jou nal o he Eu opean Ce amic Socie y, ol. 41, no. 7, pp. 4086–4097, July 2021, doi: 10.1016/j.jeu ce amsoc.2020.12.029. [2] L. Penescu, T. S o a, S. S egemann, J. Pi e s, E. Fio ina, R. Augus o, C. Schmi ze , F. Wenande e al., "Technical Design Repo o a Ca bon-11 T ea men Facili y", F on ie s in Medicine, ol. 8, 2021, doi:10.3389/ med.2021.697235 [3] P. Ja din e al., “A om- o-ion ans o ma ion ime in singly cha ged ECRIS”, Nuclea Ins umen s and Me hods in Physics Resea ch Sec ion B: Beam In e ac ions wi h Ma e ials and A oms, ol. 225, no. 3, pp. 374–382, 2004, doi: 10.1016/j.nimb.2004.06.004. [4] L. Penescu, R. Ca he all, J. Le y, and T. S o a, “De elopmen o high e iciency Ve sa ile A c Discha ge Ion Sou ce a CERN ISOLDE”, Re iew o Scien i ic Ins umen s, ol. 81, no. 2, 2010, doi: 10.1063/1.3271245. [5] F. Maldonado Millan, T. Day Goodac e, and A. Go be g, “Mul iphysics simula ion o a FEBIAD ion sou ce”, Nuclea Ins umen s and Me hods in Physics Resea ch Sec ion B: Beam In e ac ions wi h Ma e ials and A oms, ol. 463, pp. 302–304, Jan. 2020, doi: 10.1016/j.nimb.2019.04.078. [6] M. Tsuji, T. Tanoue, K. Nakano, and Y. Nishimu a, “Decomposi ion o CO2 in o CO and O in a Mic owa e-Exci ed Discha ge Flow o CO2/He o CO2/A Mix u es”, Chemis y Le e s, ol. 30, no. 1, pp. 22–23, 2001, doi: 10.1246/cl.2001.22. [7] G. Ju e, “Law ence Be keley Na ional Labo a o , yBe keley, Cali o nia”, XRDS, ol. 17, no. 4, pp. 58– 59, 2011, doi: 10.1145/1961678.1961690. [8] M. Salahshoo and M. Aslaninejad, “Resonance su ace, mic owa e powe abso p ion, and plasma densi y dis ibu ion in an elec on cyclo on esonance ion sou ce”, Physical Re iew Accele a o s and Beams, ol. 22, no. 4, p. 043402, 2019, doi: 10.1103/PhysRe AccelBeams.22.043402. [9] D.E. Done s, E.D. Done s, E.E. Done s, V.V. Salniko and V.B. Shu o , "P oduc ion o highly cha ged ion beams K 32+, Xe44+, Au54+ wi h Elec on S ing Ion Sou ce (ESIS) K ion-2 and co esponding basic and applied s udies", Jou nal o Ins umen a ion, ol. 5, 2010, doi: 10.1088/1748- 0221/5/09/C09001 [10] D.E. Done s, E.D. Done s, E.E. Done s, V.V. Salniko , V.B. Shu o , E.M. Sy esin, "Fo ma ion o high in ensi e adioac i e ca bon ion beams in elec on s ing ion sou ce", P oceedings o HIAT09, Venice, I aly, 2009, doi: 10.1088/1748-0221/5/09/C09001 [11] D.E. Done s e al. "Design o a no el ubula elec on s ing ion sou ce (TESIS)", P oceedings o EPAC08, Genoa, I aly, 2008